Skip to Main Content

Alan M. Gilbert


3300 Wells Fargo Center, 90 South Seventh Street, Minneapolis, MN 55402-4140


Alan Gilbert practices primarily in the areas of securities, corporate finance, mergers and acquisitions, and general corporate and commercial matters. He represents issuers (both seasoned and emerging companies), underwriters, and placement agents in connection with private placements and public securities offerings, including IPO's and other underwritten public offerings, registered direct offerings, PIPE (private investment in public equity) financings, and reverse merger transactions, as well as venture capital, private equity, and retail private placements. 

Alan also represents public and private companies in merger and acquisition transactions and advises public companies on matters related to SEC regulatory compliance, corporate governance, and executive compensation. He joined Maslon in 1998 and became a partner of the firm in 2006.


  • Issuer's counsel in connection with initial public offerings, follow-on public offerings, PIPE offerings, equity line financing and/or other alternative public financing transactions, including for Kona Grill, Inc., a publicly traded restaurant company (NASDAQ: KONA), ZIOPHARM Oncology, Inc., a publicly traded biotechnology company (NASDAQ: ZIOP), Global Traffic Network, Inc., a publicly traded provider of custom traffic and news reports to radio and television stations outside the U.S. (NASDAQ: GNET), WPT Enterprises, Inc., the branded entertainment and consumer products company that produced the World Poker Tour® (NASDAQ: WPTE) and El Capitan Precious Metals, Inc. (OTCQB: ECPN), among others.
  • Underwriter and placement agent counsel in connection with several public and private securities transactions, including initial public offerings and/or follow-on offerings of PokerTek, Inc. (NASDAQ: PTEK), Wireless Ronin Technologies, Inc. (NASDAQ: RNIN) n/k/a Creative Realities, Inc. (OTCQB: CREX), Urologix, Inc., (OTCQB: ULGX), BIO-key, International, Inc. (OTCBB: BKYI), Sajan, Inc. (NASDAQ: SAJA) and Intricon Corp (NASDAQ: IIN).
  • Counsel development stage and other private companies in connection with venture capital and strategic financing transactions.
  • Counsel to both public companies and private operating companies in reverse merger transactions, including those involving "public shell" reverse acquisitions. 
  • Outside general corporate and securities counsel to several public and private companies in connection with securities reporting and compliance, general corporate, commercial and executive compensation matters.
  • Purchaser's counsel in connection with the acquisition of:
    • Mercer Milling Co. by Triple Crown Nutrition, Inc., a manufacturer and distributor of premium horse feed throughout the United States;
    • JAZME, LLC dba Alliance Steel Service, a Minneapolis-based scrap metal recycling company (and subsequently as principal outside counsel, including in connection with several acquisitions, joint ventures and other strategic transactions);
    • Certain boating brand assets from Genmar Holdings, Inc. and its affiliates by J & D Acquisitions, LLC in an auction sale process conducted under Section 363 of Chapter 11 of the U.S. Bankruptcy Code;
    • Cash-N-Pawn International, Ltd., a multi-location regional chain of pawn shops (and subsequently in connection with acquisitions of additional pawn shop locations and the subsequent sale of the entire company); and
    • More than 15 business acquisitions by a publicly held provider of branded identity apparel programs and facility services.
  • Seller(s)' counsel in connection with the sale of:
    • Advanced Circulatory Systems, Inc., a manufacturer of medical devices and related software solutions to Zoll Medical Corporation. 
    • Field Solutions, Inc. to Field Nation, a leading work platform connecting organizations with independent contractors;
    • DestinationRX, a provider of Web-based shopping and enrollment systems for consumers of Medicare health plans, to Connecture, Inc.; and
    • Travanti Pharma, Inc., a developer of drug delivery systems, to Teikoku Pharma USA, Inc.


Recognized in Chambers USA: America’s Leading Lawyers for Business, Corporate/M&A, Minnesota, 2016, 2018

January 1, 2010
January 1, 2009
January 1, 2007
+ View All Presentations View All Presentations


Thank you for your interest in contacting us by email.

Please do not submit any confidential information to Maslon via email on this website. By communicating with us we are not establishing an attorney-client relationship, and information you submit will not be protected by the attorney-client privilege and cannot be treated as confidential. A client relationship will not be formed until we have entered into a formal agreement. You should also be aware that we may currently represent parties whose interests may be adverse to yours, and we reserve the right to continue to represent them notwithstanding any communication we receive from you.

If you would like to discuss possible representation, please call one of our attorneys directly or use our general line (p 612.672.8200). We can then fully discuss our intake procedures and, if appropriate, introduce you to an attorney suited to assist with your matter. Alternatively, you may send us an email containing a general inquiry subject to these terms.

If you accept the terms of this notice and would like to send an email, click on the "Accept" button below. Otherwise, please click "Decline."